Organicell OTC Stock Analysis


USD 0.0429  0.0017  4.13%   

The new price hike of Organicell Regenerative may encourage stakeholders to take a closer look at the company as it is trading at a share price of 0.0429 on 229,429 in trading volume. The company executives may have good odds in positioning the company resources to exploit market volatility in October. The stock standard deviation of daily returns for 90 days investing horizon is currently 10.34. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Organicell Regenerative partners.
Please check Your Equity Center.
The Organicell Regenerative otc stock analysis report makes it easy to digest most publicly released information about Organicell Regenerative and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Organicell OTC Stock analysis module also helps to analyze the Organicell Regenerative price relationship with some important fundamental indicators such as market cap and management efficiency.

Organicell OTC Stock Analysis Notes

About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. Organicell Regenerative had not issued any dividends in recent years. Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.The quote for Organicell Regenerative Medicine is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Organicell Regenerative Medicine contact Ricardo Prats at 888 963 7881 or learn more at

Organicell Regenerative Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Organicell Regenerative's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Organicell Regenerative Medicine or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Organicell Regenerative is way too risky over 90 days horizon
Organicell Regenerative has some characteristics of a very speculative penny stock
Organicell Regenerative appears to be risky and price may revert if volatility continues
The company currently holds 1.3 M in liabilities with Debt to Equity (D/E) ratio of 22.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Organicell Regenerative has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Organicell Regenerative until it has trouble settling it off, either with new capital or with free cash flow. So, Organicell Regenerative's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Organicell Regenerative sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Organicell to invest in growth at high rates of return. When we think about Organicell Regenerative's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 6.37 M. Net Loss for the year was (5.52 M) with profit before overhead, payroll, taxes, and interest of 5.05 M.
Organicell Regenerative Medicine currently holds about 66 K in cash with (1.62 M) of positive cash flow from operations.
Roughly 48.0% of Organicell Regenerative outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Organicell Regenerative exotic insider transaction detected

Organicell Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Organicell Regenerative is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Organicell Regenerative Medicine backward and forwards among themselves. Organicell Regenerative's institutional investor refers to the entity that pools money to purchase Organicell Regenerative's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Howard Capital Management Group LlcCommon Shares23.3 K1000
William Harris Investors IncCommon Shares10 KK
William Harris Investors IncCommon Shares10 K1000
William Harris Investors IncCommon Shares10 K1000
William Harris Investors IncCommon Shares10 KK
Note, although Organicell Regenerative's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Organicell Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 44.1 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Organicell Regenerative's market, we take the total number of its shares issued and multiply it by Organicell Regenerative's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Organicell Profitablity

Organicell Regenerative's profitability indicators refer to fundamental financial ratios that showcase Organicell Regenerative's ability to generate income relative to its revenue or operating costs. If, let's say, Organicell Regenerative is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Organicell Regenerative's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Organicell Regenerative's profitability requires more research than a typical breakdown of Organicell Regenerative's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (86.63) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (82.36) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.82.

Management Efficiency

The entity has return on total asset (ROA) of (186.09) % which means that it has lost $186.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (51.61) %, meaning that it created substantial loss on money invested by shareholders. Organicell Regenerative management efficiency ratios could be used to measure how well organicell regenerative manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 28th of September, Organicell Regenerative holds the Semi Deviation of 6.66, coefficient of variation of 456.68, and Risk Adjusted Performance of 0.2489. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Organicell Regenerative, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Organicell Regenerative, which can be compared to its competitors. Please check Organicell Regenerative information ratio, as well as the relationship between the value at risk and expected short fall to decide if Organicell Regenerative is priced some-what accurately, providing market reflects its current price of 0.0429 per share. As Organicell Regenerative appears to be a penny stock we also advise to check out its total risk alpha numbers.

Organicell Regenerative Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Organicell Regenerative price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.

Organicell Regenerative Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Organicell Regenerative insiders, such as employees or executives, is commonly permitted as long as it does not rely on Organicell Regenerative's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Organicell Regenerative insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Organicell Regenerative Predictive Daily Indicators

Organicell Regenerative intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Organicell Regenerative otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Organicell Regenerative Forecast Models

Organicell Regenerative time-series forecasting models is one of many Organicell Regenerative's otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Organicell Regenerative's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Organicell OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Organicell Regenerative prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Organicell shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual OTC such as Organicell Regenerative. By using and applying Organicell OTC Stock analysis, traders can create a robust methodology for identifying Organicell entry and exit points for their positions.
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida. Organicell Regenerative operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 22 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Organicell Regenerative to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Financial Widgets Now


Financial Widgets

Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
All  Next Launch Module
Please check Your Equity Center. Note that the Organicell Regenerative information on this page should be used as a complementary analysis to other Organicell Regenerative's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Organicell OTC Stock analysis

When running Organicell Regenerative price analysis, check to measure Organicell Regenerative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organicell Regenerative is operating at the current time. Most of Organicell Regenerative's value examination focuses on studying past and present price action to predict the probability of Organicell Regenerative's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Organicell Regenerative's price. Additionally, you may evaluate how the addition of Organicell Regenerative to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Organicell Regenerative's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organicell Regenerative. If investors know Organicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organicell Regenerative listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Organicell Regenerative is measured differently than its book value, which is the value of Organicell that is recorded on the company's balance sheet. Investors also form their own opinion of Organicell Regenerative's value that differs from its market value or its book value, called intrinsic value, which is Organicell Regenerative's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organicell Regenerative's market value can be influenced by many factors that don't directly affect Organicell Regenerative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organicell Regenerative's value and its price as these two are different measures arrived at by different means. Investors typically determine Organicell Regenerative value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organicell Regenerative's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.